This page covers carcinoma cervix thesis topics across cervical screening, cytology, human papillomavirus testing and colposcopy; clinical profile and stage at presentation; imaging and clinicopathological correlation; histopathology and surgical findings; and treatment-related outcomes for MD Obstetrics and Gynaecology candidates. The emphasis is on cervical cancer research topics that can be completed within one thesis period using women already undergoing screening, colposcopy, biopsy, staging investigations, surgery or chemoradiation, together with routinely generated clinical records. A shortlisted question should then be converted into an endpoint-specific obstetrics and gynaecology carcinoma cervix protocol and a submission-ready obstetrics and gynaecology carcinoma cervix synopsis.
Last reviewed and updated: September 2026 · 2026–27 admissions
Screening, Cytology, Human Papillomavirus Testing, and Colposcopy
- Diagnostic Accuracy of Visual Inspection with Acetic Acid for Detection of Cervical Intraepithelial Neoplasia Grade 2 or Worse Among Women Attending a Gynecology Outpatient Department: A Cross-Sectional Study
- Correlation of Cervical Cytology Findings with Colposcopic Impression and Histopathology in Women with Abnormal Cervical Screening Results: A Cross-Sectional Analytical Study
- Diagnostic Accuracy of Conventional Papanicolaou Smear Compared with Colposcopy-Directed Biopsy for Detection of High-Grade Cervical Intraepithelial Neoplasia: A Cross-Sectional Study
- Association of High-Risk Human Papillomavirus Positivity with Cervical Cytology Abnormalities in Women Undergoing Cervical Cancer Screening: A Cross-Sectional Analytical Study
- Comparison of Visual Inspection with Acetic Acid and Papanicolaou Smear for Detection of Cervical Precancerous Lesions: A Comparative Cross-Sectional Study
- Diagnostic Accuracy of Colposcopic Reid Index for Prediction of High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Screening Tests: A Cross-Sectional Study
- Correlation of Transformation Zone Type with Colposcopic and Histopathological Findings in Women Evaluated for Cervical Precancerous Lesions: A Cross-Sectional Analytical Study
- Prevalence and Pattern of Cervical Cytological Abnormalities Among Women Attending a Tertiary Care Gynecology Outpatient Department: A Cross-Sectional Observational Study
- Association of Sociodemographic and Reproductive Risk Factors with Abnormal Cervical Cytology Among Women Undergoing Screening: A Cross-Sectional Analytical Study
- Diagnostic Performance of Visual Inspection with Lugol's Iodine for Detection of Cervical Intraepithelial Neoplasia Among Screen-Positive Women: A Cross-Sectional Study
- Correlation of High-Risk Human Papillomavirus Infection with Severity of Cervical Intraepithelial Neoplasia on Histopathology: A Cross-Sectional Analytical Study
- Frequency and Histopathological Outcomes of Atypical Squamous Cells of Undetermined Significance on Cervical Cytology: A Retrospective Observational Study
- Histopathological Correlation of Low-Grade and High-Grade Squamous Intraepithelial Lesions Detected on Cervical Cytology: A Cross-Sectional Analytical Study
- Diagnostic Accuracy of Colposcopy for Detection of Cervical Intraepithelial Neoplasia Grade 2 or Worse in Women with High-Risk Human Papillomavirus Positivity: A Cross-Sectional Study
- Association of Postcoital Bleeding with Cytological, Colposcopic, and Histopathological Abnormalities of the Cervix: A Cross-Sectional Analytical Study
- Prevalence of High-Risk Human Papillomavirus Infection and Associated Clinical Factors Among Women with Abnormal Cervical Cytology: A Cross-Sectional Study
- Comparison of Colposcopic Impression and Histopathological Diagnosis in Women with Clinically Suspicious Cervical Lesions: A Comparative Cross-Sectional Study
- Predictors of High-Grade Cervical Intraepithelial Neoplasia Among Women Referred for Colposcopy Following Abnormal Cervical Screening: A Cross-Sectional Analytical Study
- Association of Menopausal Status with Adequacy of Cervical Cytology and Colposcopic Evaluation in Women Undergoing Cervical Cancer Screening: A Cross-Sectional Analytical Study
- Diagnostic Yield of Endocervical Sampling in Women with Abnormal Cervical Screening and Inadequate Visualization of the Transformation Zone: A Cross-Sectional Observational Study
Clinical Profile, Risk Factors, and Stage at Presentation
- Clinical and Sociodemographic Profile of Women with Newly Diagnosed Carcinoma Cervix at a Tertiary Care Centre: A Cross-Sectional Observational Study
- Association of Age at Marriage, Age at First Childbirth, and Parity with Stage at Diagnosis of Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Socioeconomic and Educational Status with Stage at Presentation Among Women with Carcinoma Cervix: A Cross-Sectional Analytical Study
- Clinical Spectrum of Presenting Symptoms and Their Association with Stage of Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Duration of Symptoms Before Hospital Presentation with Locally Advanced Carcinoma Cervix: A Cross-Sectional Analytical Study
- Prevalence of Anaemia and Its Association with Clinical Stage Among Women with Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Nutritional Status and Body Mass Index with Stage at Presentation in Women with Carcinoma Cervix: A Cross-Sectional Analytical Study
- Comparison of Clinical Characteristics of Premenopausal and Postmenopausal Women with Carcinoma Cervix: A Comparative Cross-Sectional Study
- Association of Tobacco Exposure with Histological Type and Stage of Carcinoma Cervix: A Cross-Sectional Analytical Study
- Reproductive and Sexual Health Factors Associated with Carcinoma Cervix: A Case-Control Study
- Comparison of Risk Factor Profiles Between Women with Carcinoma Cervix and Women with High-Grade Cervical Intraepithelial Neoplasia: A Comparative Cross-Sectional Study
- Association of Prior Cervical Cancer Screening History with Stage at Diagnosis Among Women with Carcinoma Cervix: A Cross-Sectional Analytical Study
- Frequency of Common Comorbidities and Their Association with Clinical Presentation in Women with Carcinoma Cervix: A Cross-Sectional Observational Study
- Association of Clinical Tumour Size on Pelvic Examination with International Federation of Gynecology and Obstetrics Stage in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Correlation of Parametrial Involvement on Clinical Examination with Imaging Findings in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Pattern of Vaginal, Parametrial, and Pelvic Sidewall Involvement at Initial Evaluation of Carcinoma Cervix: A Cross-Sectional Observational Study
- Association of Hydronephrosis with Stage and Clinical Characteristics in Women with Carcinoma Cervix: A Cross-Sectional Analytical Study
- Clinical Profile and Stage Distribution of Carcinoma Cervix in Women Aged 40 Years or Younger: A Retrospective Observational Study
- Comparison of Clinical Presentation and Stage Distribution Between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix: A Comparative Cross-Sectional Study
- Factors Associated with Advanced-Stage Presentation of Carcinoma Cervix at a Tertiary Care Centre: A Case-Control Study
Imaging, Staging, and Clinicopathological Correlation
- Correlation of Clinical Examination and Magnetic Resonance Imaging for Local Staging of Carcinoma Cervix: A Cross-Sectional Analytical Study
- Diagnostic Accuracy of Magnetic Resonance Imaging for Detection of Parametrial Invasion in Carcinoma Cervix Using Clinically Indicated Findings as Reference: A Cross-Sectional Study
- Diagnostic Accuracy of Magnetic Resonance Imaging for Detection of Pelvic Lymph Node Involvement in Carcinoma Cervix Using Available Histopathological or Clinical Reference Standards: A Cross-Sectional Study
- Correlation of Magnetic Resonance Imaging Tumour Size with Histopathological Tumour Size in Surgically Managed Early-Stage Carcinoma Cervix: A Cross-Sectional Analytical Study
- Comparison of Clinical and Magnetic Resonance Imaging Assessment of Tumour Size in Carcinoma Cervix: A Comparative Cross-Sectional Study
- Association of Magnetic Resonance Imaging–Detected Parametrial Invasion with Clinical Stage in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Correlation of Ultrasound-Detected Hydronephrosis with Disease Stage in Women with Carcinoma Cervix: A Cross-Sectional Analytical Study
- Diagnostic Performance of Pelvic Ultrasonography for Assessment of Cervical Tumour Size Compared with Magnetic Resonance Imaging in Carcinoma Cervix: A Comparative Cross-Sectional Study
- Association of Pelvic Lymph Node Characteristics on Imaging with Stage and Histological Type of Carcinoma Cervix: A Cross-Sectional Analytical Study
- Correlation of Magnetic Resonance Imaging–Detected Vaginal Involvement with Clinical Examination in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Correlation of Magnetic Resonance Imaging–Detected Pelvic Sidewall Involvement with Clinical Staging Findings in Locally Advanced Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Tumour Morphology on Magnetic Resonance Imaging with Histological Type and Grade in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Diagnostic Accuracy of Magnetic Resonance Imaging for Detection of Urinary Bladder Invasion in Locally Advanced Carcinoma Cervix: A Cross-Sectional Study
- Diagnostic Accuracy of Magnetic Resonance Imaging for Detection of Rectal Invasion in Locally Advanced Carcinoma Cervix: A Cross-Sectional Study
- Correlation of Clinical Stage with Radiological Stage in Newly Diagnosed Carcinoma Cervix: A Comparative Cross-Sectional Study
- Frequency and Distribution of Radiologically Enlarged Pelvic and Para-Aortic Lymph Nodes in Carcinoma Cervix and Their Association with Clinical Stage: A Cross-Sectional Observational Study
- Association of Cervical Tumour Volume on Magnetic Resonance Imaging with Parametrial and Nodal Involvement in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Correlation of Preoperative Magnetic Resonance Imaging Findings with Operative and Histopathological Findings in Early-Stage Carcinoma Cervix: A Cross-Sectional Analytical Study
- Comparison of Clinical Examination and Magnetic Resonance Imaging for Detection of Vaginal and Parametrial Extension in Carcinoma Cervix: A Comparative Cross-Sectional Study
- Factors Associated with Discordance Between Clinical and Magnetic Resonance Imaging Staging in Carcinoma Cervix: A Cross-Sectional Analytical Study
Histopathology, Surgical Findings, and Prognostic Factors
- Histopathological Spectrum of Carcinoma Cervix and Its Association with Age and Clinical Stage: A Cross-Sectional Analytical Study
- Association of Histological Grade with Tumour Size and Stage in Squamous Cell Carcinoma of the Cervix: A Cross-Sectional Analytical Study
- Frequency and Clinicopathological Correlates of Lymphovascular Space Invasion in Surgically Managed Carcinoma Cervix: A Cross-Sectional Observational Study
- Association of Depth of Stromal Invasion with Lymphovascular Space Invasion and Pelvic Lymph Node Metastasis in Early-Stage Carcinoma Cervix: A Cross-Sectional Analytical Study
- Correlation of Clinical Tumour Size with Histopathological Tumour Size in Surgically Managed Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Histopathological Tumour Size with Parametrial Involvement in Early-Stage Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Lymphovascular Space Invasion with Pelvic Lymph Node Metastasis in Surgically Managed Carcinoma Cervix: A Cross-Sectional Analytical Study
- Frequency and Predictors of Pelvic Lymph Node Metastasis in Early-Stage Carcinoma Cervix Undergoing Radical Surgery: A Cross-Sectional Analytical Study
- Association of Parametrial Involvement with Tumour Size, Stromal Invasion, and Lymph Node Status in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Comparison of Clinicopathological Characteristics of Squamous Cell Carcinoma and Adenocarcinoma of the Cervix: A Comparative Cross-Sectional Study
- Frequency and Determinants of Positive or Close Surgical Margins Following Radical Surgery for Carcinoma Cervix: A Retrospective Observational Study
- Correlation of Preoperative Clinical Stage with Final Histopathological Risk Factors in Surgically Managed Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Vaginal Margin Involvement with Tumour Size and Histopathological Characteristics in Surgically Managed Carcinoma Cervix: A Cross-Sectional Analytical Study
- Pattern of Pelvic Lymph Node Involvement in Early-Stage Carcinoma Cervix Undergoing Radical Surgery: A Cross-Sectional Observational Study
- Association of Number of Pelvic Lymph Nodes Retrieved with Detection of Nodal Metastasis in Surgically Managed Carcinoma Cervix: A Retrospective Analytical Study
- Concordance Between Preoperative Biopsy Histology and Final Surgical Histopathology in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Association of Pretreatment Haemoglobin Level with Histological Grade and Disease Stage in Carcinoma Cervix: A Cross-Sectional Analytical Study
- Clinicopathological Predictors of Intermediate- and High-Risk Histopathological Features After Radical Surgery for Early-Stage Carcinoma Cervix: A Cross-Sectional Analytical Study
- Comparison of Operative and Histopathological Parametrial Involvement in Women Undergoing Radical Surgery for Carcinoma Cervix: A Comparative Cross-Sectional Study
- Association of Gross Tumour Morphology with Histopathological Type, Grade, and Stage in Carcinoma Cervix: A Cross-Sectional Analytical Study
Treatment, Perioperative Outcomes, and Immediate Treatment Response
- Perioperative Outcomes of Radical Hysterectomy with Pelvic Lymphadenectomy for Early-Stage Carcinoma Cervix: A Prospective Observational Study
- Comparison of Intraoperative Blood Loss, Operative Duration, and Immediate Postoperative Morbidity Between Different Surgical Approaches Used for Clinically Indicated Radical Hysterectomy in Carcinoma Cervix: A Comparative Observational Study
- Clinical and Surgical Predictors of Intraoperative Blood Loss During Radical Hysterectomy for Carcinoma Cervix: A Prospective Observational Study
- Frequency and Risk Factors for Perioperative Blood Transfusion in Women Undergoing Radical Surgery for Carcinoma Cervix: A Cross-Sectional Analytical Study
- Pattern and Predictors of Immediate Postoperative Complications Following Radical Hysterectomy for Carcinoma Cervix: A Prospective Observational Study
- Association of Body Mass Index with Operative Duration, Blood Loss, and Immediate Postoperative Morbidity Following Radical Hysterectomy for Carcinoma Cervix: A Prospective Observational Study
- Association of Preoperative Haemoglobin Level with Perioperative Outcomes in Women Undergoing Surgery for Carcinoma Cervix: A Prospective Observational Study
- Comparison of Perioperative Outcomes Between Women with and Without Prior Abdominal Surgery Undergoing Radical Hysterectomy for Carcinoma Cervix: A Comparative Observational Study
- Factors Associated with Prolonged Hospital Stay Following Radical Surgery for Carcinoma Cervix: A Prospective Observational Study
- Incidence and Predictors of Intraoperative Urinary Tract Injury During Radical Hysterectomy for Carcinoma Cervix: A Retrospective Observational Study
- Incidence and Clinical Predictors of Early Postoperative Bladder Dysfunction Following Radical Hysterectomy for Carcinoma Cervix: A Prospective Observational Study
- Pattern of Acute Treatment-Related Toxicities During Concurrent Chemoradiation for Locally Advanced Carcinoma Cervix: A Prospective Observational Study
- Association of Pretreatment Haemoglobin Level with Acute Toxicity and Treatment Completion During Concurrent Chemoradiation for Carcinoma Cervix: A Prospective Observational Study
- Factors Associated with Unplanned Treatment Interruptions During Concurrent Chemoradiation for Locally Advanced Carcinoma Cervix: A Prospective Observational Study
- Association of Baseline Nutritional Status with Acute Treatment Toxicity in Women Receiving Concurrent Chemoradiation for Carcinoma Cervix: A Prospective Observational Study
- Clinical and Haematological Predictors of Acute Haematological Toxicity During Concurrent Chemoradiation for Carcinoma Cervix: A Prospective Observational Study
- Immediate Clinical Response Following Completion of Concurrent Chemoradiation for Locally Advanced Carcinoma Cervix and Its Association with Pretreatment Clinical Factors: A Prospective Observational Study
- Association of Pretreatment Tumour Size with Immediate Clinical Response to Concurrent Chemoradiation in Locally Advanced Carcinoma Cervix: A Prospective Observational Study
- Comparison of Acute Gastrointestinal and Genitourinary Toxicities Across Clinical Stages in Women Receiving Concurrent Chemoradiation for Carcinoma Cervix: A Comparative Observational Study
- Predictors of Complete Planned Treatment Delivery Without Interruption in Women Undergoing Concurrent Chemoradiation for Locally Advanced Carcinoma Cervix: A Prospective Observational Study
Not the obstetrics and gynaecology subspeciality you need? Carcinoma cervix is one section of our full obstetrics and gynaecology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
All Obstetrics and Gynaecology Topics →
📌 Updated for 2026–2027 MD Obstetrics and Gynaecology Carcinoma Cervix admissions
The research framework was reviewed for human papillomavirus-based screening, cytology and colposcopy, stage at presentation, imaging-pathology concordance, surgical risk factors and immediate treatment outcomes.
- Most projects can be completed with routine cervical screening records, cytology, human papillomavirus testing where available, colposcopy, biopsy histopathology, pelvic imaging, operative findings and oncology treatment records already generated during standard care.
- Research-only biopsies, additional magnetic resonance imaging, extra radiation exposure, non-indicated endocervical sampling or experimental molecular testing are not required unless clinically justified and specifically approved.
- Publication potential is strongest when the disease endpoint is fixed before recruitment, screen-negative women are not lost from verification pathways, pretreatment staging is separated from postoperative pathology, and treatment outcomes are assessed at a prespecified time point.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full carcinoma cervix protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside carcinoma cervix protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Carcinoma cervix research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the carcinoma cervix research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the carcinoma cervix research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a carcinoma cervix research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A carcinoma cervix IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning carcinoma cervix research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the carcinoma cervix research proposal is the document assessed at the start of it.
Kuwait — KIMS. A carcinoma cervix study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the carcinoma cervix proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A carcinoma cervix dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full carcinoma cervix research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a carcinoma cervix PhD or MMed proposal →
🔥 Trending research areas in Carcinoma Cervix for 2026–27
Current cervical-cancer research is increasingly centred on risk-based human papillomavirus screening and more reproducible triage of women who test positive.
- Human papillomavirus DNA-based primary screening: recent international guidance continues the shift away from cytology or visual inspection alone towards human papillomavirus testing as the primary screening method, creating practical implementation and triage questions.
- Extended human papillomavirus genotyping: genotype-specific risk stratification is increasingly used to refine management of women with positive human papillomavirus tests rather than treating all oncogenic types as equivalent.
- Self-collected human papillomavirus samples: self-sampling is expanding as an option for women who are never screened or underscreened, making agreement, acceptability and linkage-to-colposcopy studies increasingly relevant.
- p16/Ki-67 dual-stain triage: dual-stain cytology is being incorporated into risk-based pathways for human papillomavirus-positive women and offers a practical research area where liquid-based cytology and appropriate laboratory support are available.
Protocol and synopsis guidance
What a Carcinoma Cervix protocol must contain
A carcinoma cervix protocol must first define which part of the disease pathway is being studied: screening, precancer, invasive cancer staging, surgical pathology or treatment response. The inclusion criteria, index test, disease endpoint and reference standard should then match that question. Screening studies should distinguish women undergoing routine screening from women already referred because of an abnormal result, because referral populations have a much higher prevalence of cervical intraepithelial neoplasia and will produce different estimates of diagnostic performance.
Verification must be planned for the whole study population. Women with abnormal cytology, positive human papillomavirus testing, suspicious visual inspection or abnormal colposcopy are much more likely to undergo biopsy than women with negative tests. If histopathology is available mainly for test-positive women, the study has partial verification and sensitivity or specificity may be biased. The protocol should therefore state how test-negative women are classified and whether an accepted follow-up pathway, repeat testing or another appropriate reference is used.
Pretreatment and post-treatment variables must remain separate. Clinical stage, magnetic resonance imaging stage, tumour size, haemoglobin and hydronephrosis should be recorded before treatment begins. Surgical histopathology is available only in selected operable disease and should not be used as the universal reference for women with locally advanced cancer receiving chemoradiation. Treatment-response studies should also define the response time point rather than mixing examinations performed at different intervals after therapy.
Carcinoma Cervix synopsis versus Carcinoma Cervix protocol
A carcinoma cervix synopsis can state the clinical question, population, screening or staging method and principal endpoint briefly. The full protocol must convert those statements into reproducible definitions for specimen collection, cytology category, human papillomavirus result, colposcopic impression, biopsy threshold, histopathological endpoint, clinical or radiological stage, treatment status and the exact time point at which outcomes are measured.
For screening studies, the protocol should distinguish cervical intraepithelial neoplasia grade 2 or worse, cervical intraepithelial neoplasia grade 3 or worse and invasive carcinoma because these are different endpoints. For staging studies, it should specify whether the comparison is clinical examination versus imaging agreement or imaging accuracy against an independent operative or histopathological reference. For treatment studies, baseline variables must precede surgery, radiotherapy or chemotherapy if they are to be analysed as predictors.
Sample size and statistical analysis
Sample size should follow the primary endpoint. A prevalence study of cytological abnormalities needs an expected proportion and desired precision; a diagnostic-accuracy study needs enough women with and without the prespecified histopathological endpoint; and a comparative staging study needs enough paired assessments to estimate disagreement or diagnostic performance with useful confidence intervals. Rare outcomes such as bladder invasion or perioperative urinary tract injury usually require a larger dataset than a small single-centre thesis can provide.
Agreement and accuracy answer different questions. Clinical examination and magnetic resonance imaging performed in the same woman can be compared for agreement, but neither is automatically correct. Kappa or weighted kappa can assess categorical agreement, while sensitivity and specificity require an independent reference standard. Likewise, correlation between tumour sizes does not establish that two measurement methods agree closely enough to be interchangeable.
Multivariable analysis should include only clinically justified predictors and preserve the temporal sequence between predictor and outcome. Screening studies should account for verification patterns, while surgical cohorts should acknowledge that they represent selected operable disease and should not be generalised automatically to all women with carcinoma cervix.
Frequently Asked Questions – Carcinoma Cervix Thesis Topics (2026–27)
1. How do I choose a feasible Carcinoma Cervix thesis topic for 2026 admission?
Choose one part of the cervical-cancer pathway for which the department has reliable volume and complete records. Screening clinics can support projects on cytology, human papillomavirus testing, visual inspection or colposcopy; oncology services can support stage-at-presentation and treatment studies; and surgical units can support imaging-pathology or operative-histopathology correlation. Feasibility depends more on access to the required reference standard and complete follow-up than on the total number of cervical cases alone.
2. Which study designs are accepted for Carcinoma Cervix research?
Suitable designs include descriptive and analytical cross-sectional studies, comparative studies, diagnostic-accuracy studies, case-control studies, retrospective or prospective cohorts, agreement studies and short-term treatment-outcome studies. The design should follow the research question. Screening prevalence can be cross-sectional, while treatment completion, acute toxicity or postoperative morbidity requires longitudinal observation even if follow-up is limited to the treatment period or hospital admission.
3. What should I settle with my guide before registering a Carcinoma Cervix topic?
Settle whether the project concerns screening, precancer, invasive cancer staging, surgical pathology or treatment response; the exact disease endpoint; the reference standard; whether women with negative screening tests receive verification; and the time point for pretreatment or post-treatment measurements. Also confirm that the required cytology, human papillomavirus testing, colposcopy, biopsy, imaging, operative or radiotherapy records are consistently available.
4. Can colposcopy or cervical cytology be treated as the gold standard in my thesis?
Not when the research question is whether cytology or colposcopy detects histological precancer. Cytology and colposcopy are screening or triage assessments with their own false-positive and false-negative results. When histological cervical intraepithelial neoplasia is the disease endpoint, an appropriately obtained biopsy or excisional specimen is usually the reference among women who undergo tissue diagnosis. The protocol must still address women who do not undergo biopsy so that verification is not limited to screen-positive cases.
5. What is the difference between a Carcinoma Cervix synopsis and protocol?
The synopsis is the concise institutional submission describing the research question, objectives, design and broad methods. The protocol is the operational document that fixes the study population, screening or staging test, specimen and reporting method, histopathological endpoint, verification pathway, pretreatment variables, treatment-response time point, missing-data rules and the statistical analysis corresponding to every objective.
6. What ethics issues are important in Carcinoma Cervix research?
Research should distinguish tests and procedures performed for clinical care from those added solely for the study. Additional cervical biopsy, endocervical sampling, magnetic resonance imaging, contrast administration, radiation exposure or venepuncture should not be added merely to complete a thesis unless clinically justified and specifically approved. If extra blood sampling is genuinely required, the purpose and permitted blood volume should be stated. Record-based or archived pathology studies may qualify for an ethics-approved waiver of individual consent.
Prospective participants should provide informed consent, with guardian consent and age-appropriate assent where a minor is eligible under applicable law and institutional policy. Cytology images, colposcopic photographs, pathology images and imaging data should be anonymised before research export, and separate consent is required for identifiable photographs or video. The protocol should name the clinical escalation pathway for newly detected high-grade cervical intraepithelial neoplasia, invasive carcinoma, hydronephrosis, suspected bladder or rectal invasion, severe anaemia or another finding requiring prompt oncological assessment.
7. What is the biggest methodological error in a Carcinoma Cervix thesis?
The sharpest error is calculating diagnostic accuracy when histopathological verification is concentrated in women whose screening or colposcopy result is already abnormal. Those women are more likely to undergo biopsy, while test-negative women may have no tissue diagnosis at all. The resulting dataset contains a selected subgroup in which apparent sensitivity can be inflated and specificity becomes difficult to interpret.
The protocol should preserve the index-test result and define what happens to the negative arm before recruitment begins. Structured repeat testing, appropriate follow-up or another accepted pathway may be necessary when biopsy of every screen-negative woman would be unethical. Accuracy should not be claimed unless the reference pathway supports classification of both positive and negative participants.
8. How does a Carcinoma Cervix MD thesis differ from PhD and Gulf board research pathways?
An MD synopsis is usually a focused residency dissertation based on screening, staging, surgery or treatment data available within one training period. A PhD proposal requires a broader original research programme, a clearer knowledge gap and usually greater methodological development, multicentre recruitment or longer follow-up.
Residents beyond the Indian MD pathway should align the project with the mandatory board research project required within SCFHS and Saudi Board training, Arab Board of Health Specializations requirements, and institutional or programme processes linked to DHP, DHA, DOH and MOHAP. The clinical question may remain similar, but supervision, ethics approval, proposal format, milestones and evidence of completion should follow the relevant programme.
9. When should I register my Carcinoma Cervix thesis topic?
Register after confirming case volume, the exact disease endpoint, the index test or staging method, reference standard, verification pathway, treatment status and availability of the required records, but before prospective recruitment or research-specific data collection begins. For retrospective work, fix the study period, eligibility rules and analysis plan before reviewing outcomes so that cases are not selected according to biopsy, surgical or treatment results already known.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
